journal article·2025-12-02

In Situ Supply and Anchoring of Glycosaminoglycan by Dual-Modified Hydrogel Loaded with Glycoengineered Stem Cells for Attenuating Disc Degeneration

Yi Li, Jian Cao, Chengzhen Liang, Yuang Zhang, Kesi Shi, Haibin Xu, Kaishun Xia, Xianpeng Huang, Chao Yu, Jiangjie Chen, Feng Cheng, Jinyang Chen, Ronghao Wang, Kanbin Wang, Fangcai Li, Qixin Chen, Jianqing Gao, Xiaopeng Zhou

ACS Nano· Volume 19· Issue 47
Publisher page

Abstract

Stem cells hold great promise for repairing degenerated nucleus pulposus (NP) in intervertebral disc degeneration (IVDD) via differentiating into NP-like cells and replenishing the extracellular matrix (ECM). However, the harsh environment in degenerated NP contributes to poor survival, low differentiation efficiency, and matrix catabolism, hampering stem cells' long-term transplantation and efficacy. Herein, a hyaluronic acid (HA)-based hydrogel (Pep-aGel) functionalized with collagen mimetic peptide and amination is fabricated to deliver glycoengineered stem cells for NP repair. The peptide (GFOGER), which contains the integrin recognition sequence of collagen, is selectively bound to the upregulated integrin-β1 of glycoengineered stem cells, thereby promoting their NP-like differentiation. The amination introduced amino groups in hydrogel and further enhanced the integration of cell-secreted glycosaminoglycans (GAGs) on the HA chains, which mimicked the biosynthesis of Aggrecan, creating an NP-like nanostructure in the hydrogel. Pep-aGel loading with glycoengineered cells showed injectable properties and significantly improved disc height, extracellular matrix content, and GAG deposition in rat degenerated discs. This approach established a self-sufficient system that consists of NP cell replenishment, in situ ECM supply, and GAG anchoring, which may offer a concise, yet synergistic, strategy for the regeneration of IVDD.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Spine and Intervertebral Disc Pathology · Osteoarthritis Treatment and Mechanisms · Nerve injury and regeneration

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics Surgery, The Second Affiliated Hospital, School of Medicine

Zhejiang University

Orthopedics Research Institute of Zhejiang University

Key Laboratory of Motor System Disease Precision Research and Therapy of Zhejiang Province

Clinical Research Center of Motor System Disease of Zhejiang Province

The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital

College of Pharmaceutical Sciences

Department of Pharmacy, The Second Affiliated Hospital, School of Medicine

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province · Basic Public Welfare Projects in Zhejiang Province

References (77)

Show source-provided references
1. 10.1016/S0140-6736(21)00733-910.1016/S0140-6736(21)00733-9 ↗
2. 10.1001/jama.2020.073410.1001/jama.2020.0734 ↗
3. 10.1097/01.brs.0000253960.57051.de10.1097/01.brs.0000253960.57051.de ↗
4. 10.1016/j.bbagen.2014.07.01310.1016/j.bbagen.2014.07.013 ↗
5. 10.1080/03008207.2018.149973110.1080/03008207.2018.1499731 ↗
6. 10.1002/advs.20220733410.1002/advs.202207334 ↗
7. 10.1007/s00586-009-1092-810.1007/s00586-009-1092-8 ↗
8. 10.1186/ar247310.1186/ar2473 ↗
9. 10.1002/biof.126610.1002/biof.1266 ↗
10. 10.1016/j.tibtech.2006.01.01010.1016/j.tibtech.2006.01.010 ↗
11. 10.1016/j.carbpol.2020.11707910.1016/j.carbpol.2020.117079 ↗
12. 10.1021/nn506602810.1021/nn5066028 ↗
13. 10.1038/nrrheum.2015.1310.1038/nrrheum.2015.13 ↗
14. 10.1002/advs.20230476110.1002/advs.202304761 ↗
15. 10.1016/j.carbpol.2021.11882810.1016/j.carbpol.2021.118828 ↗
16. 10.1016/j.actbio.2018.09.04410.1016/j.actbio.2018.09.044 ↗
17. 10.1002/adfm.20240123210.1002/adfm.202401232 ↗
18. 10.1038/s41467-023-39604-010.1038/s41467-023-39604-0 ↗
19. 10.1002/adhm.20220182410.1002/adhm.202201824 ↗
20. 10.1126/sciadv.adg023410.1126/sciadv.adg0234 ↗
21. 10.1016/j.biomaterials.2017.05.01710.1016/j.biomaterials.2017.05.017 ↗
22. 10.1002/anie.20160112310.1002/anie.201601123 ↗
23. 10.1007/s00109-002-0382-y10.1007/s00109-002-0382-y ↗
24. 10.1093/glycob/cwt03910.1093/glycob/cwt039 ↗
25. 10.1523/JNEUROSCI.22-20-08869.200210.1523/JNEUROSCI.22-20-08869.2002 ↗
26. 10.1016/j.yexcr.2004.01.01610.1016/j.yexcr.2004.01.016 ↗
27. 10.1016/j.biomaterials.2022.12146310.1016/j.biomaterials.2022.121463 ↗
28. 10.1002/adfm.20230655410.1002/adfm.202306554 ↗
29. 10.1021/acsnano.9b0759810.1021/acsnano.9b07598 ↗
30. 10.1126/sciadv.ado912010.1126/sciadv.ado9120 ↗
31. 10.1038/sj.cr.729010610.1038/sj.cr.7290106 ↗
32. 10.1242/jcs.18867210.1242/jcs.188672 ↗
33. 10.1016/j.biomaterials.2022.12199110.1016/j.biomaterials.2022.121991 ↗
34. 10.7150/thno.2976610.7150/thno.29766 ↗
35. 10.3109/1745367750898928310.3109/17453677508989283 ↗
36. 10.1038/nrm362010.1038/nrm3620 ↗
37. 10.1038/3504665910.1038/35046659 ↗
38. 10.3390/biology1011118910.3390/biology10111189 ↗
39. 10.1016/j.actbio.2018.03.01910.1016/j.actbio.2018.03.019 ↗
40. 10.1038/879210.1038/8792 ↗
41. 10.1002/jsp2.108110.1002/jsp2.1081 ↗
42. 10.1242/dev.119.3.64910.1242/dev.119.3.649 ↗
43. 10.1016/j.bioactmat.2022.07.02410.1016/j.bioactmat.2022.07.024 ↗
44. 10.1038/s41551-019-0500-610.1038/s41551-019-0500-6 ↗
45. 10.1016/j.bioactmat.2021.03.01410.1016/j.bioactmat.2021.03.014 ↗
46. 10.1016/j.bioactmat.2021.03.01810.1016/j.bioactmat.2021.03.018 ↗
47. 10.1088/1758-5090/acb57210.1088/1758-5090/acb572 ↗
48. 10.1002/advs.20230472210.1002/advs.202304722 ↗
49. 10.1126/science.284.5411.14310.1126/science.284.5411.143 ↗
50. 10.1002/jbm.a.3608910.1002/jbm.a.36089 ↗
51. 10.3892/etm.2021.1045010.3892/etm.2021.10450 ↗
52. 10.3390/ijms2010252310.3390/ijms20102523 ↗
53. 10.1016/S0092-8674(00)80622-410.1016/S0092-8674(00)80622-4 ↗
54. 10.1074/jbc.275.1.3510.1074/jbc.275.1.35 ↗
55. 10.1007/s00441-009-0834-610.1007/s00441-009-0834-6 ↗
56. 10.1023/B:ABME.0000017538.72511.4810.1023/B:ABME.0000017538.72511.48 ↗
57. 10.1038/s41467-019-14000-910.1038/s41467-019-14000-9 ↗
58. 10.1016/j.biomaterials.2014.03.05510.1016/j.biomaterials.2014.03.055 ↗
59. 10.1038/s41536-022-00274-z10.1038/s41536-022-00274-z ↗
60. 10.1016/j.biomaterials.2010.06.00110.1016/j.biomaterials.2010.06.001 ↗
61. 10.1167/iovs.63.1.1310.1167/iovs.63.1.13 ↗
62. 10.1016/j.biomaterials.2020.12061210.1016/j.biomaterials.2020.120612 ↗
63. 10.1016/j.actbio.2012.09.01610.1016/j.actbio.2012.09.016 ↗
64. 10.1063/1.495357110.1063/1.4953571 ↗
65. 10.1021/acsnano.1c0068210.1021/acsnano.1c00682 ↗
66. 10.1038/s41598-018-28293-110.1038/s41598-018-28293-1 ↗
67. 10.1038/s41563-019-0307-610.1038/s41563-019-0307-6 ↗
68. 10.1038/s41584-020-00568-w10.1038/s41584-020-00568-w ↗
69. 10.1016/j.mtbio.2022.10033610.1016/j.mtbio.2022.100336 ↗
70. 10.1002/term.321610.1002/term.3216 ↗
71. 10.1002/jsp2.103710.1002/jsp2.1037 ↗
72. 10.1016/j.carbpol.2020.11692210.1016/j.carbpol.2020.116922 ↗
73. 10.1016/j.carbpol.2019.01.02010.1016/j.carbpol.2019.01.020 ↗
74. 10.1002/adma.20230489610.1002/adma.202304896 ↗
75. 10.1016/j.actbio.2024.04.01710.1016/j.actbio.2024.04.017 ↗
76. 10.1016/j.biomaterials.2015.01.02110.1016/j.biomaterials.2015.01.021 ↗
77. 10.1093/glycob/cwg08210.1093/glycob/cwg082 ↗